The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Komarov A.L.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Shakhmatova O.O.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Vlasova E.E.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Lavrikova T.A.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Vasilyev V.P.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Latypov R.S.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Galyautdinov D.M.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Kurbanov S.K.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Fedotova L.M.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Panchenko E.P.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Shiryaev A.A.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Antithrombotic therapy after coronary artery bypass grafting: how to improve prognosis and preserve grafts

Authors:

Komarov A.L., Shakhmatova O.O., Vlasova E.E., Lavrikova T.A., Vasilyev V.P., Latypov R.S., Galyautdinov D.M., Kurbanov S.K., Fedotova L.M., Panchenko E.P., Shiryaev A.A.

More about the authors

Journal: Russian Cardiology Bulletin. 2026;21(1): 5‑12

DOI: 10.17116/Cardiobulletin2026210115

Read: 807 times

Contact the author
Table of contents

ANTITHROMBOTIC THERAPY AFTER CORONARY ARTERY BYPASS GRAFTING: HOW TO IMPROVE PROGNOSIS AND PRESERVE GRAFTS
ANTITHROMBOTIC THERAPY AFTER CORONARY ARTERY BYPASS GRAFTING: HOW TO IMPROVE PROGNOSIS AND PRESERVE GRAFTS

To cite this article:

Komarov AL, Shakhmatova OO, Vlasova EE, et al. Antithrombotic therapy after coronary artery bypass grafting: how to improve prognosis and preserve grafts. Russian Cardiology Bulletin. 2026;21(1):5‑12. (In Russ.)
https://doi.org/10.17116/Cardiobulletin2026210115

Подписка 2026 Кардиологический вестник (Russian Cardiology Bulletin)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Visceral obesity is a reve­rsible factor in pathogenesis of major cardiovascular diseases. Russian Cardiology Bulletin. 2025;(3):11-16
Factors dete­rmining the effe­ctiveness of various anti­thrombotic therapy regi­mens after coro­nary artery bypass surgery in patients with diffuse lesions and small diameter of coro­nary arte­ries: a 12-month prospective follow-up. Russian Cardiology Bulletin. 2025;(3):25-35
Strain echo­cardiography for perioperative asse­ssment of the left ventricle and left atrium in patients unde­rgoing coro­nary artery bypass surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):269-279
Imme­diate resu­lts of coro­nary bypass grafting without touching the aorta in patients with multiple-vessel disease: a single-center retrospective study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):280-285
Atrial fibrillation recu­rrences after catheter treatment and labo­ratory markers: is there a correlation?. Russian Journal of Preventive Medi­cine. 2025;(7):56-62
Opti­mal cardioplegia for coro­nary artery bypass grafting in patients with heart failure: a randomized study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):405-411
Predictors of acute kidney disease in patients with stable angina after coro­nary artery bypass grafting. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):412-417
Cognitive reha­bilitation technology using a combination of postural training and simu­ltaneous cognitive task in prevention of cognitive impairment after coro­nary artery bypass grafting. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):418-427
Intraoperative myocardial infa­rction or repe­rfusion syndrome? Features of ECG diagnostics. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):428-433
Left atrial redu­ction in mitral valve surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):460-470
Abstract:

Antithrombotic therapy is an integral component of treatment designed to ensure long-term patency of grafts and improve prognosis in patients undergoing coronary artery bypass grafting. The authors review optimal antithrombotic treatment strategies for different categories of patients — those with stable coronary artery disease, acute coronary syndromes, concomitant atrial fibrillation, and heart valve disease. A particular attention is paid to clinical situations associated with high risk of graft failure (complex coronary reconstructions, “compromised” distal bed, coronary endarterectomy). Standard aspirin monotherapy and various options for “intensified” treatment, including addition of the second antithrombotic drug (P2Y12 receptor blocker or anticoagulant), are considered.

Keywords:

coronary artery bypass grafting
diffuse lesion
small (<1.5 mm) diameter of arteries
antithrombotic therapy
anticoagulants
atrial fibrillation
coronary endarterectomy

Authors:

Komarov A.L.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Shakhmatova O.O.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Vlasova E.E.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Lavrikova T.A.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Vasilyev V.P.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Latypov R.S.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Galyautdinov D.M.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Kurbanov S.K.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Fedotova L.M.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Panchenko E.P.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Shiryaev A.A.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Received:

23.01.2026

Accepted:

03.02.2026

Close metadata

References:

  1. Gaudino M, Di Franco A, Bhatt DL et al. The association between coronary graft patency and clinical status in patients with coronary artery disease. Eur Heart J. 2021 Apr 7;42(14):1433-1441. https://doi.org/10.1093/eurheartj/ehab096
  2. Sandner S, Antoniades C, Caliskan E et al. Intra-operative and post-operative management of conduits for coronary artery bypass grafting: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Surgery and the European Association for Cardio-Thoracic Surgery Coronary Task Force. Eur Heart J. 2025 Jan 3;46(1):19-34.  https://doi.org/10.1093/eurheartj/ehae654
  3. Goldman S, Copeland J, Mortiz T et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a veterans administration cooperative study. Circulation. 1988;77:1324—32.  https://doi.org/10.1161/01.CIR.77.6.1324
  4. Musleh G, Dunning J. Does aspirin 6 h after coronary artery bypass grafting optimise graft patency? Interact Cardiovasc Thorac Surg. 2003;2:413-5.  https://doi.org/10.1016/S1569-9293(03)00181-6
  5. Gaudino M, Sandner S, An KR et al. Graft failure after coronary artery bypass grafting and its association with patient characteristics and clinical events: a pooled individual patient data analysis of clinical trials with imaging follow-up. Circulation. 2023;148:1305-15.  https://doi.org/10.1161/CIRCULATIONAHA.123.064090
  6. Sandner S, Gaudino M, Agewall S et al. Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2025 Aug 2;67(8):ezaf243. https://doi.org/10.1093/ejcts/ezaf243
  7. Choi KH, Song YB, Jeong DS et al. Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. Stable ischaemic heart disease after coronary artery bypass grafting. Eur Heart J Cardiovasc Pharmacother. 2021;7:517-26.  https://doi.org/10.1093/ehjcvp/pvaa080
  8. Björklund E, Malm CJ, Nielsen SJ et al. Comparison of Midterm Outcomes Associated With Aspirin and Ticagrelor vs Aspirin Monotherapy After Coronary Artery Bypass Grafting for Acute Coronary Syndrome. JAMA Netw Open. 2021 Aug 2;4(8):e2122597. https://doi.org/10.1001/jamanetworkopen.2021.22597
  9. Jeppsson A, James S, Moller CH et al. TACSI Trial Group.; TACSI Trial Group. Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome. N Engl J Med. 2025 Dec 11;393(23):2313-2323. https://doi.org/10.1056/NEJMoa2508026
  10. Solo K, Lavi S, Kabali C et al. Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis. BMJ. 2019;367:l5476. https://doi.org/10.1136/bmj.l5476
  11. Vrints C, Andreotti F, Koskinas KC et al. ESC Scientific Document Group. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024 Sep 29;45(36):3415-3537. https://doi.org/10.1093/eurheartj/ehae177
  12. Lavrikova TA, Komarov AL, Vlasova EE et al. Factors determining the effectiveness of various antithrombotic therapy regimens after coronary artery bypass surgery in patients with diffuse lesions and small diameter of coronary arteries: a 12-month prospective follow-up. Russian Cardiology Bulletin. 2025;20(3):25-35.(In Russ.). https://doi.org/10.17116/Cardiobulletin20252003125
  13. Lavrikova T.A., Komarov A.L., Vlasova E.E. et al. The role of antithrombotic therapy in ensuring the patency of bypass grafts to small-diameter arteries in patients with coronary heart disease/Therapy. — 2025. — Vol. 11, No. S6. — P. 29. — EDN LNBDAM. (In Russ.). ISSN:2412-4036eISSN:2713-1823
  14. Lamy A, Eikelboom J, Sheth T et al. Rivaroxaban, aspirin, or both to prevent early coronary bypass graft occlusion: the COMPASS-CABG study. J Am Coll Cardiol. 2019;73:121-30.  https://doi.org/10.1016/j.jacc.2018.10.048
  15. Barbarash O.L., Karpov Yu.A., Panov A.V., et.al. 2024 Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2024;29(9):6110. (In Russ.). https://doi.org/10.15829/1560-4071-2024-6110
  16. Jeppsson A; Rocca B; Hansson EC; et al. EACTS Scientific Document Group. 2024 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg. 2024 Dec 26;67(1):ezae355. https://doi.org/10.1093/ejcts/ezae355
  17. Douketis JD, Spyropoulos AC, Duncan J et al. Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med. 2019;179:1469-78.  https://doi.org/10.1001/jamainternmed.2019.2431
  18. Byrne RA, Rossello X, Coughlan JJ et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023 Oct 12;44(38):3720-3826. https://doi.org/10.1093/eurheartj/ehad191
  19. Golitsyn S.P., Golukhova E.Z., Mikhailov E.N., Atrial fibrillation and flutter. Clinical guidelines 2025. (In Russ.). 14.01.2025  https://2b1938e6-492b-4229-97a0831bf8c6d707.selstorage.ru/extra_files/rBxxvEvDnRtQldxjIAs9PwtB9TIZjYiGLTHUXpEb.pdf
  20. van der Meer J, Hillege HL, Kootstra GJ et al. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Lancet. 1993 Jul 31;342(8866):257-64.  https://doi.org/10.1016/0140-6736(93)91815-4
  21. Pizzi R, Cimini LA, Ageno W et al. Direct Oral Anticoagulants for Pulmonary Embolism. Hamostaseologie. 2024 Jun;44(3):206-217.  https://doi.org/10.1055/a-2105-8736
  22. Segiet-Swiecicka A., Dabrowski R. Anticoagulant monotherapy versus anticoagulant therapy in combination with single antiplatelet agent in patients after coronary artery bypass grafting — analysis of real-world data. European Heart Journal. 2024;45(Supplement_1), ehae666.1432. https://doi.org/10.1093/eurheartj/ehae666.1432
  23. Skibniewski M, Venetsanos D, Ahlsson A et al. Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry. Am Heart J. 2023 Mar;257:69-77.  https://doi.org/10.1016/j.ahj.2022.12.001
  24. Taha A, Nielsen SJ, Bergfeldt L et al. New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Outcome: A Population-Based Nationwide Study From the SWEDEHEART Registry. J Am Heart Assoc. 2021 Jan 5;10(1):e017966. https://doi.org/10.1161/JAHA.120.017966
  25. van de Kar MRD, van Brakel TJ, Van’t Veer M et al. Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis. Eur Heart J. 2024 Aug 3;45(29):2620-2630. https://doi.org/10.1093/eurheartj/ehae267
  26. Herrmann FEM, Taha A, Rezk M et al. Outcomes in Early Postoperative Versus Late New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting. J Am Heart Assoc. 2025 Oct 7;14(19):e043026. https://doi.org/10.1161/JAHA.125.043026
  27. Awad AK, Elbahloul MA, Al-Omoush O et al. Impact of postoperative atrial fibrillation (POAF) on outcomes after coronary artery bypass grafting: A meta-analysis of unique 247,270 patients from 50 studies. Am Heart J Plus. 2025. Sep. 18;59:100621. https://doi.org/10.1016/j.ahjo.2025.100621
  28. Herrmann FEM, Jeppsson A, Kirov H et al. Long-Term Continuous Monitoring of New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting. JAMA. 2025 Nov 25;334(20):1827-1835. https://doi.org/10.1001/jama.2025.14891
  29. Van Gelder IC, Rienstra M, Bunting KV et al. ESC Scientific Document Group. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024 Sep 29;45(36):3314-3414. https://doi.org/10.1093/eurheartj/ehae176
  30. Joglar JA, Chung MK, Armbruster AL et al. Peer Review Committee Members. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 2;149(1):e1-e156. https://doi.org/10.1161/CIR.0000000000001193
  31. Fragão-Marques M, Teixeira F, Mancio J et al. Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis. Thromb J. 2021 Nov 19;19(1):89.  https://doi.org/10.1186/s12959-021-00342-2
  32. Cheah DS, Tsai K, Kurpad KP et al. Trends and Outcomes of Anticoagulation for Post-Operative Atrial Fibrillation After Coronary Artery Bypass Graft. Pacing Clin Electrophysiol. 2025 Dec;48(12):1444-1450. https://doi.org/10.1111/pace.70069
  33. van de Kar MRD, van Brakel TJ, Houterman S et al. Real-world anticoagulant use and clinical outcomes in postoperative atrial fibrillation after coronary artery bypass grafting: a nationwide practice-based cohort from the Netherlands Heart Registration. Eur Heart J Qual Care Clin Outcomes. 2025 Oct 18:qcaf124. https://doi.org/10.1093/ehjqcco/qcaf124
  34. Lemesle G, Didier R, Steg PG et al. AQUATIC Trial Investigators. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. N Engl J Med. 2025 Oct 23;393(16):1578-1588. https://doi.org/10.1056/NEJMoa2507532
  35. Doğan AC, Demir AR, Ateşli Yazıcı A et al. Left Atrial Diameter Index Predicts Cerebrovascular Events After POAF Following CABG. Thorac Cardiovasc Surg. 2025 Nov 14.  https://doi.org/10.1055/a-2747-7537
  36. Ivanov S. Yu., Bondarenko B. B. On the peculiarities of atrial fibrillation induced by the coronary artery bypass surgery. Bulletin of St. Petersburg University. Medicine. 2014. No. 4. P. 26-35. (In Russ.). ISSN: 1818-2909eISSN: 2587-5876 
  37. Chang S, Lombardo A, Smith I et al. Early use of non-vitamin K antagonist oral anticoagulants after cardiac surgery compared with warfarin for postoperative atrial fibrillation. ANZ J Surg. 2025 Jun;95(6):1135-1141. https://doi.org/10.1111/ans.70045
  38. Praz F, Borger MA, Lanz J et al. ESC/EACTS Scientific Document Group. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2025 Nov 21;46(44):4635-4736. https://doi.org/10.1093/eurheartj/ehaf194
  39. Reade MC. Temporary epicardial pacing after cardiac surgery: a practical review: part 1: general considerations in the management of epicardial pacing. Anaesthesia. 2007 Mar;62(3):264-71.  https://doi.org/10.1111/j.1365-2044.2007.04950.x
  40. Massel DR, Little SH. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database Syst Rev. 2013 Jul 9;2013(7): CD003464. https://doi.org/10.1002/14651858.CD003464.pub2
  41. Vahanian A, Beyersdorf F, Praz F et al. ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632.  https://doi.org/10.1093/eurheartj/ehab395
  42. Gaudino M, Glineur D. Technical aspects of modern coronary artery bypass surgery. ELSEVIER 2021. ISBN: 978-0-12-820348-4 
  43. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Jan 18;145(3):e18-e114. https://doi.org/10.1161/CIR.0000000000001038
  44. Ghatanatti R, Teli A. Coronary Endarterectomy: Recent Trends. J Clin Diagn Res. 2017 Aug;11(8):PE01-PE04. https://doi.org/10.7860/JCDR/2017/27036.10339
  45. LaPar DJ, Anvari F, Irvine JN Jr, Kern JA, Swenson BR, Kron IL, Ailawadi G. The impact of coronary artery endarterectomy on outcomes during coronary artery bypass grafting. J Card Surg. 2011 May;26(3):247-53.  https://doi.org/10.1111/j.1540-8191.2011.01247.x
  46. Schmitto JD, Kolat P, Ortmann P, Popov AF, Coskun KO, Friedrich M, Sossalla S, Toischer K, Mokashi SA, Tirilomis T, Baryalei MM, Schoendube FA. Early results of coronary artery bypass grafting with coronary endarterectomy for severe coronary artery disease. J Cardiothorac Surg. 2009 Sep 22;4:52.  https://doi.org/10.1186/1749-8090-4-52
  47. Marzban M, Karimi A, Ahmadi H, Davoodi S, Abbasi K, Movahedi N, Salehiomran A, Abbasi SH, Kawoosi Y, Yazdanifard P. Early outcomes of double-vessel coronary endarterectomy in comparison with single-vessel coronary endarterectomy. Tex Heart Inst J. 2008;35(2):119-24. PMID: 18612488; PMCID: PMC2435433.
  48. Kumar S, Agarwala S, Talbot C, Nair RU. Long term survival after coronary endarterectomy in patients undergoing combined coronary and valvular surgery — a fifteen year experience. J Cardiothorac Surg. 2008 Mar 26;3:15.  https://doi.org/10.1186/1749-8090-3-15
  49. Visker Ya. Yu., Kovalchuk D. N., Molchanov A. N., Ibragimov O. R. Coronary endarterectomy in myocardial revascularization. Russian Journal of Cardiology. 2021;26(8):4310. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4310
  50. Krivosheeva E.N., Komarov A.L., Galyautdinov D.M., Vlasova E.E., Akchurin R.S., Panchenko E.P. Long-term outcomes of coronary artery bypass graft surgery in patients with widespread atherosclerotic lesions of the coronary and peripheral vascular basins (based on the REGATA long-term antithrombotic therapy registry). Aterotromboz = Atherothrombosis. 2021;11(2):30-43. (In Russ.). https://doi.org/10.21518/2307-1109-2021-11-2-30-43
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.